Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

559
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
559
The Bronchial Tree01:23

The Bronchial Tree

7.1K
The human bronchi and bronchial tree play a crucial role in the respiratory system, facilitating the exchange of oxygen and carbon dioxide. Let's delve into the intricate structure and functions of these respiratory components.
The trachea, commonly known as the windpipe, is a tube that connects the larynx (voice box) to the bronchi. At a point called the carina, it bifurcates into two primary bronchi. The right primary bronchus is wider, shorter, and more vertical than the left primary...
7.1K
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

4.1K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
4.1K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

932
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
932
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

888
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
888
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

1.9K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.9K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Implementing Digital Respiratory Technologies for People With Respiratory Conditions: Scoping Review.

Journal of medical Internet research·2026
Same author

Neurodevelopmental Profile of Children With MARS1-Related Pulmonary Alveolar Proteinosis: A Cohort Study.

American journal of medical genetics. Part A·2026
Same author

Development and validity evidence for the probabilistic reasoning test in undergraduate medical students.

BMC medical education·2026
Same author

Treatable traits in paediatric bronchiectasis: current practice and a proposed checklist.

European journal of pediatrics·2026
Same author

Reply to "Validation and interpretation of the Pediatric Asthma Treatment Burden Questionnaire: methodological considerations".

The journal of allergy and clinical immunology. In practice·2026
Same author

Two-Year Outcomes in Children Born With a Congenital Pulmonary Malformation.

Pediatrics·2026

Video Experimental Relacionado

Updated: Feb 22, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.6K

Rasgos tratables en niños con bronquiectasia

Joséphine Annereau1, Apolline Gonsard2, Rola Abou Taam3

  • 1Department of Paediatric Pulmonology and Allergology, AP-HP, University Hospital Necker-Enfants Malades, F-75015 Paris, France; Université Paris Cité, Inria, Inserm, HeKA, F-75015 Paris, France.

Paediatric respiratory reviews
|February 20, 2026
PubMed
Resumen

El enfoque de rasgos tratables (TT) identifica factores modificables en la bronquiectasia pediátrica. Se necesita más investigación para respaldar estos rasgos específicamente en niños.

Palabras clave:
BronquiectasiaComorbilidadAdherencia a la medicaciónPediatríaMedicina de precisiónRasgos

Más Videos Relacionados

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
05:56

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

Published on: May 12, 2023

5.5K
The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections
06:57

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections

Published on: May 8, 2017

9.6K

Videos de Experimentos Relacionados

Last Updated: Feb 22, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.6K
A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
05:56

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

Published on: May 12, 2023

5.5K
The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections
06:57

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections

Published on: May 8, 2017

9.6K

Área de la Ciencia:

  • Neumología Pediátrica
  • Medicina de Precisión

Sus antecedentes:

  • La bronquiectasia en niños es una afección respiratoria crónica compleja.
  • El manejo estandarizado es crucial, y las guías internacionales mejoran la consistencia.
  • El enfoque de rasgos tratables (TT) ofrece un marco de medicina de precisión.

Objetivo del estudio:

  • Identificar posibles rasgos tratables (TT) en la bronquiectasia pediátrica.
  • Evaluar la base de evidencia para estos TT en niños.
  • Guiar la evaluación sistemática y la investigación futura.

Principales métodos:

  • Revisión exhaustiva de la literatura.
  • Identificación de posibles TT en los dominios etiológico, pulmonar, extrapulmonar y conductual/ambiental.
  • Evaluación del nivel de evidencia para cada TT en poblaciones pediátricas.

Principales resultados:

  • Se identificaron 40 posibles rasgos tratables (TT) para la bronquiectasia pediátrica.
  • Se encontró evidencia limitada que respalda muchos TT específicamente en niños.
  • Gran parte de los datos existentes se extrapolan de estudios en adultos o de otras enfermedades respiratorias.

Conclusiones:

  • El enfoque TT proporciona un marco dinámico para la evaluación individualizada en la bronquiectasia pediátrica.
  • Existe una necesidad urgente de ensayos clínicos específicos para niños para validar estos rasgos.
  • Se requiere más investigación para fortalecer la base de evidencia para los TT en esta población.